Patents by Inventor Ishtiaq E. Saaem

Ishtiaq E. Saaem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11130948
    Abstract: Aspects of the invention relate to methods, compositions for designing and producing a target nucleic acid. In particular, aspects of the invention relate to the multiplex synthesis of target polynucleotides.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: September 28, 2021
    Assignee: Gen9, Inc.
    Inventors: Joseph Jacobson, Daniel Schindler, Ishtiaq E. Saaem, Scott S. Lawton, Martin J. Goldberg, Michael E. Hudson, Li-yun A. Kung
  • Publication number: 20190203201
    Abstract: Aspects of the invention relate to methods, compositions for designing and producing a target nucleic acid. In particular, aspects of the invention relate to the multiplex synthesis of target polynucleotides.
    Type: Application
    Filed: March 12, 2019
    Publication date: July 4, 2019
    Inventors: Joseph Jacobson, Daniel Schindler, Ishtiaq E. Saaem, Scott S. Lawton, Martin J. Goldberg, Michael E. Hudson, Li-yun A. Kung
  • Publication number: 20190010529
    Abstract: Aspects of the invention relate to methods, compositions for synthesizing high fidelity oligonucleotides.
    Type: Application
    Filed: July 18, 2018
    Publication date: January 10, 2019
    Inventors: Ishtiaq E. Saaem, Michael E. Hudson, Stephen F. Archer, Sophea Sann-Rorth, Ellen J. Sanchez, Joseph Jacobson
  • Publication number: 20180355353
    Abstract: Artificial transcription terminators and their use are provided herein. In one aspect, a non-naturally occurring nucleic acid sequence can comprise a Y-X-Z stem-loop, wherein: Y is a nucleotide sequence of 10 to 30 nucleotides in length; X is a nucleotide sequence of 3 to 12 nucleotides in length, each nucleotide therein not base pairing with any other nucleotide within X; and Z is a nucleotide sequence of 10 to 50 nucleotides in length and having at least 70% complementarity to Y.
    Type: Application
    Filed: November 29, 2016
    Publication date: December 13, 2018
    Applicant: Gen9, Inc.
    Inventor: Ishtiaq E. Saaem
  • Patent number: 10053719
    Abstract: Aspects of the invention relate to methods, compositions for synthesizing high fidelity oligonucleotides.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: August 21, 2018
    Assignee: Gen9, Inc.
    Inventors: Ishtiaq E. Saaem, Michael E. Hudson, Stephen F. Archer, Sophea Sann-Rorth, Ellen J. Sanchez, Joseph Jacobson
  • Publication number: 20170349925
    Abstract: Methods and compositions relate to the assembly of high fidelity nucleic acids. Specifically, nucleic acid molecules having a desired predetermined sequence can be assembled after failure to assemble in conventional assembly. Aspects of the disclosure relate to methods of assembling a target nucleic acid molecule having a desired or predetermined sequence.
    Type: Application
    Filed: October 20, 2015
    Publication date: December 7, 2017
    Inventors: Joseph Jacobson, Ishtiaq E. Saaem
  • Publication number: 20150368687
    Abstract: Aspects of the invention relate to methods, compositions for synthesizing high fidelity oligonucleotides.
    Type: Application
    Filed: March 13, 2014
    Publication date: December 24, 2015
    Applicant: Gen9, Inc.
    Inventors: Ishtiaq E. Saaem, Michael E. Hudson, Stephen F. Archer, Sophea Sann-Rorth, Ellen J. Fanti, Joseph Jacobson